WHERT 2025-1 · Report 6

Monthly distribution report, December 15, 2025

Collection period November 1, 2025 to November 30, 2025. Payment date December 15, 2025.

Pool
ItemAmount
Beginning pool balance$362,164,325.33
Scheduled payments (principal portion)-$8,204,143.52
Prepayments and buyouts-$1,473,271.67
Defaulted contracts-$99,451.25
Ending pool balance$352,387,458.89
Pool factor0.8545116
Contracts outstanding3,659
Weighted average remaining term36.67 months
Collections and fees
ItemAmount
Total collections$12,253,612.47
of which Utilization Pricing above minimums$329,849.60
Recoveries on defaulted contracts$58,271.55
Servicing fee$301,803.60
Trustee and backup servicer fees$2,916.67
Released to the depositor$1,551,825.93
Notes
ClassBeginning balanceInterest paidPrincipal paidEnding balanceNote factor
Class A-1$26,008,754.44$96,882.61$9,028,936.16$16,979,818.280.2176900
Class A-2$142,300,000.00$558,527.50$0.00$142,300,000.001.0000000
Class A-3$108,150,000.00$439,810.00$0.00$108,150,000.001.0000000
Class B$24,600,000.00$106,805.00$0.00$24,600,000.001.0000000
Class C$18,400,000.00$86,480.00$0.00$18,400,000.001.0000000
Class D$15,000,000.00$79,625.00$0.00$15,000,000.001.0000000
Total$334,458,754.44$1,368,130.11$9,028,936.16$325,429,818.28
Delinquency, share of ending pool balance
Days past dueShare
31 to 600.75%
61 to 900.25%
91 to 1200.13%
More than 1200.09%
Total more than 600.47%
Credit enhancement and losses
ItemAmount
Overcollateralization$26,957,640.61
as a share of the pool7.65%
Reserve account balance$4,123,846.17
Cumulative net losses$305,258.45
Cumulative net loss ratio0.074%
Enrolled assets in service hold at period end3

Collection account: Fenwright Trust Company, N.A., for the benefit of the noteholders, account ending 5129. Reserve account: same, ending 5136.

Prepared by Wardmore Health Capital, LLC, as servicer, under the sale and servicing agreement dated as of June 18, 2025. The servicer certifies that, to its knowledge, this report is accurate in all material respects. Figures are unaudited. Questions: investor.reporting@wardmorehealth.com.